Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;27(2):219-30.
doi: 10.1177/0885328211399480. Epub 2011 May 17.

Structural and cellular characterization of electrospun recombinant human tropoelastin biomaterials

Affiliations

Structural and cellular characterization of electrospun recombinant human tropoelastin biomaterials

Kathryn A McKenna et al. J Biomater Appl. 2012 Aug.

Abstract

An off-the-shelf vascular graft biomaterial for vascular bypass surgeries is an unmet clinical need. The vascular biomaterial must support cell growth, be non-thrombogenic, minimize intimal hyperplasia, match the structural properties of native vessels, and allow for regeneration of arterial tissue. Electrospun recombinant human tropoelastin (rTE) as a medial component of a vascular graft scaffold was investigated in this study by evaluating its structural properties, as well as its ability to support primary smooth muscle cell adhesion and growth. rTE solutions of 9, 15, and 20 wt% were electrospun into sheets with average fiber diameters of 167 ± 32, 522 ± 67, and 735 ± 270 nm, and average pore sizes of 0.4 ± 0.1, 5.8 ± 4.3, and 4.9 ± 2.4 µm, respectively. Electrospun rTE fibers were cross-linked with disuccinimidyl suberate to produce an insoluble fibrous polymeric recombinant tropoelastin (prTE) biomaterial. Smooth muscle cells attached via integrin binding to the rTE coatings and proliferated on prTE biomaterials at a comparable rate to growth on prTE coated glass, glass alone, and tissue culture plastic. Electrospun tropoelastin demonstrated the cell compatibility and design flexibility required of a graft biomaterial for vascular applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of electrospun rTE fibers from 9, 15, and 20 wt% solutions. The rTE fibers were randomly oriented. Fiber diameters were directly proportional to the concentration of the rTE solution. The electrospun rTE fibers from 9 and 15 wt% solutions had only round cross-sections, while isolated electrospun rTE fibers from 20 wt% solutions had flat cross-sections. SEM micrographs at magnifications of 1000X, 5000X, and 10000X.
Figure 2
Figure 2
SEM micrograph of extracted native elastin from a porcine carotid artery. Scale bars indicate 10 μm.
Figure 3
Figure 3
TEM micrograph of substructure of 15 wt% electrospun rTE fibers. Voids are visualized within the fibers. Scale bar indicate 500nm.
Figure 4
Figure 4
SEM micrograph of uncross-linked electrospun rTE (left) and cross-linked electrospun prTE (right) fibers produced from a 15 wt% rTE solution. No change in fiber structure was seen using the DSS cross-linker.
Figure 5
Figure 5
Characterization of the adhesion of SMCs to adsorbed rTE. SMCs were allowed to adhere to rTE, fibronectin (Fn), collagen type I (Col), or tissue culture treated plastic (TCP) in either adhesion media or adhesion media with a blocking reagent: EDTA, Pertussis toxin, or lactose. EDTA significantly reduced SMC adhesion to the rTE and Fn coated wells. *p<0.05, compared to the same coating with adhesion media, ANOVA with a Tukey post-hoc test.
Figure 6
Figure 6
Morphology of SMCs seeded onto electrospun 15 wt% prTE for (A) 24 and (B) 48 hours. Confocal images of prTE fibers (green) with actin cytoskeleton-phalloidin (red) and nuclei (blue) of SMCs. SMC pseudopodia made attachments to individual prTE fibers (arrows in A), SMC concentrations increased between 24 and 48 hours, and SMCs formed actin stress fibers (arrows in B). Scale bar indicates 20 μm.
Figure 7
Figure 7
SMC proliferation on electrospun prTE, coated prTE, lysine D glass, and tissue culture plastic (TCP) over a 7 day time course. Cell metabolic activity was quantified using alamarBlue assay and the data normalized to the fluorescence reading at day 1. Data are average of 3 lots of rTE solutions.

Similar articles

Cited by

References

    1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 121(7):e46–e215. - PubMed
    1. Brewster DC. Prosthetic grafts. In: Rutherford RB, editor. Vascular Surgery. 4. Philadelphia: W. B. Saunders; 1995. pp. 492–521.
    1. Abbott WM, Rehring TF. Biologic and synthetic prosthetic materials for vascular conduits. In: Hobson RW, Wilson S, Veith FJ, editors. Vascular Surgery: Principles and Practice. 3. New York: Marcel Dekker; 2004. pp. 611–620.
    1. Sawyer PN, Fitzgerald J, Kaplitt MJ, Sanders RJ, Williams GM, Leather RP, Karmody A, Hallin RW, Taylor R, Fries CC. Ten year experience with the negatively charged glutaraldehyde-tanned vascular graft in peripheral vascular surgery. Initial multicenter trial. Am J Surg. 1987;154(5):533–7. - PubMed
    1. Dardik H, Wengerter K, Qin F, Pangilinan A, Silvestri F, Wolodiger F, Kahn M, Sussman B, Ibrahim IM. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J Vasc Surg. 2002;35(1):64–71. - PubMed

Publication types